A Study About Fazirsiran in People With and Without Liver Problems.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503735-17-00

Acronym

TAK-999-1001

Enrollment

Registered

2023-09-04

Start date

2023-10-05

Completion date

2025-09-03

Last updated

2025-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic impairment.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Hungary, Slovakia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026